Scholarlink

<p>Silver nanoparticles (AgNPs) were green-synthesized using Syrian bee bread (SBB) extract as a natural reducing and stabilizing agent. Optimal reaction conditions were established at 1% extract concentration, 1 mM silver nitrate, pH 9.5, and room temperature. Dynamic light scattering (DLS) analysis revealed a hydrodynamic diameter (ZA) of 61.95&#xa0;nm with a polydispersity index (PDI) of 0.347, while the zeta potential measured − 25.2 mV, indicating good colloidal stability. UV–Vis spectroscopy showed a characteristic absorption peak at 437&#xa0;nm, and field emission scanning electron microscopy (FESEM) confirmed predominantly spherical nanoparticles with an average size of ~ 30&#xa0;nm. Atomic force microscopy (AFM) showed smooth, uniform surfaces with an average size of ~ 36&#xa0;nm of spherical AgNPs. The synthesized SBB-AgNPs displayed notable antimicrobial activity, with inhibition zones of 20, 20, 22, 21, 20, and 25&#xa0;mm against <i>Staphylococcus aureus</i>,<i> Staphylococcus epidermidis</i>,<i> Escherichia coli</i>,<i> Klebsiella</i> spp., <i>Pseudomonas aeruginosa</i>, and <i>Candida albicans</i>, respectively. The minimum inhibitory concentrations (MICs) values ranged from 20 to 25&#xa0;µg/mL, while the minimum inhibitory concentrations (MBCs) were 40–50&#xa0;µg/mL demonstrating effective bactericidal potential. Cytotoxicity assessment on normal human dermal fibroblasts (NHDF) revealed that doses up to 50&#xa0;µg/mL were relatively safe and maintained high cell viability, whereas higher concentrations induced dose-dependent cytotoxicity, with an IC<sub>50</sub> value of 192.3&#xa0;µg/mL, indicating good biocompatibility. This study reports, for the first time, the use of SBB for nanoparticle synthesis, underscoring its potential as a sustainable natural source for producing eco-friendly nanomaterials. These findings demonstrate the promise of SBB-AgNPs for biomedical applications by balancing antimicrobial efficacy with cellular safety.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sustainable biosynthesis and characterization of optimized silver nanoparticles using Apis mellifera Syriaca bread with antimicrobial and biocompatibility evaluation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月5日

查看全文
  • Bayan Kaabour,
  • Ghinwa Lababidi,
  • Ibrahim Alghoraibi

摘要

Silver nanoparticles (AgNPs) were green-synthesized using Syrian bee bread (SBB) extract as a natural reducing and stabilizing agent. Optimal reaction conditions were established at 1% extract concentration, 1 mM silver nitrate, pH 9.5, and room temperature. Dynamic light scattering (DLS) analysis revealed a hydrodynamic diameter (ZA) of 61.95 nm with a polydispersity index (PDI) of 0.347, while the zeta potential measured − 25.2 mV, indicating good colloidal stability. UV–Vis spectroscopy showed a characteristic absorption peak at 437 nm, and field emission scanning electron microscopy (FESEM) confirmed predominantly spherical nanoparticles with an average size of ~ 30 nm. Atomic force microscopy (AFM) showed smooth, uniform surfaces with an average size of ~ 36 nm of spherical AgNPs. The synthesized SBB-AgNPs displayed notable antimicrobial activity, with inhibition zones of 20, 20, 22, 21, 20, and 25 mm against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa, and Candida albicans, respectively. The minimum inhibitory concentrations (MICs) values ranged from 20 to 25 µg/mL, while the minimum inhibitory concentrations (MBCs) were 40–50 µg/mL demonstrating effective bactericidal potential. Cytotoxicity assessment on normal human dermal fibroblasts (NHDF) revealed that doses up to 50 µg/mL were relatively safe and maintained high cell viability, whereas higher concentrations induced dose-dependent cytotoxicity, with an IC50 value of 192.3 µg/mL, indicating good biocompatibility. This study reports, for the first time, the use of SBB for nanoparticle synthesis, underscoring its potential as a sustainable natural source for producing eco-friendly nanomaterials. These findings demonstrate the promise of SBB-AgNPs for biomedical applications by balancing antimicrobial efficacy with cellular safety.